3 studies found for:    18160686 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Trastuzumab, Docetaxel;   Drug: Trastuzumab, Docetaxel, Bevacizumab;   Drug: Trastuzumab+Docetaxel+NPLD;   Drug: Trastuzumab+Docetaxel+NPLD+Bevacizumab
2 Recruiting Polymorphism Interaction to Predict Bevacizumab Efficacy
Condition: Metastatic Breast Cancer
Intervention:
3 Completed Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: Paclitaxel

Indicates status has not been verified in more than two years